GOG randomized, double-blind, placebo-controlled phase III trial: (A) study design; (B) progression-free survival analysis (reproduced with permission) Download scientific diagram | Design of Study GOG from publication: Time for a Level Playing Field: Inequalities in Regulatory/Approval Processes–The. ASCO Annual Meeting CHICAGO — The addition of bevacizumab as maintenance therapy to first-line treatment with standard.

Author: Kazisho Gardakora
Country: Denmark
Language: English (Spanish)
Genre: Spiritual
Published (Last): 9 June 2008
Pages: 439
PDF File Size: 17.90 Mb
ePub File Size: 2.63 Mb
ISBN: 701-6-37908-546-4
Downloads: 3270
Price: Free* [*Free Regsitration Required]
Uploader: Tejin

Stage III or IV ovarian cancer OC after primary surgery Avastin, in combination with carboplatin and paclitaxel, followed by Avastin as a single agent, is indicated for the treatment of patients with stage III or IV epithelial ovarian, fallopian tube, or primary peritoneal cancer following initial surgical resection. Recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer rOC Avastin, in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan, is indicated for the treatment of patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or goog peritoneal cancer who received no more than 2 prior chemotherapy regimens.

Avastin, in combination with carboplatin and paclitaxel, or with carboplatin and gemcitabine, followed by Avastin as a single agent, is indicated for the treatment of patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Persistent, recurrent, or metastatic cervical cancer CC Avastin, in combination with paclitaxel and cisplatin or paclitaxel and topotecan, is indicated for the treatment of patients with persistent, recurrent, or metastatic cervical cancer. Metastatic renal cell carcinoma mRCC Avastin, in combination with interferon alfa, is indicated for the treatment of metastatic renal cell carcinoma.

Avastin® (bevacizumab) Efficacy | Stage III or IV Ovarian Cancer & psOC, prOC

Recurrent Glioblastoma GBM Avastin is indicated for the treatment of recurrent glioblastoma in ggo. Avastin, in combination with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy, is indicated for the second-line 02218 of patients with metastatic colorectal cancer who have progressed on a first-line Avastin-containing regimen.

  INFORMATICS PRACTICES SUMITA ARORA CLASS 11 PDF

You may also report side effects to Genentech at The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc.

Genentech does not recommend and does not endorse the content gkg any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites. The information contained in this section of the site is intended for U.

Click “OK” if you are a healthcare professional. Avastin is not indicated for adjuvant treatment of colon cancer.

Do not administer Avastin for at least 28 days after surgery and until the wound is fully healed Discontinue in patients with wound healing goy requiring medical intervention Hemorrhage Severe or fatal hemorrhage, including hemoptysis, GI bleeding, hematemesis, central nervous system hemorrhage, epistaxis, and vaginal bleeding, occurred up to 5-fold more frequently in patients receiving Avastin.

Additional serious adverse events Additional serious and sometimes fatal adverse events with increased incidence in the Avastin-treated arm vs chemotherapy arm included: Pregnancy warning Based on the mechanism of action and animal studies, Avastin may cause fetal harm Advise female patients that Avastin may 02218 fetal harm, and to inform their healthcare provider of a known or suspected pregnancy Advise females of reproductive potential to use effective contraception during treatment with Avastin and for 6 months after the last dose of Avastin Advise nursing women that breastfeeding is not recommended during treatment tog Avastin and for 6 months following their last dose of treatment Avastin may impair fertility.

In patients receiving Avastin with lomustine, the adverse reaction profile was similar to that observed in other approved indications. These data are likely to underestimate the 02118 adverse event rates due to the reporting mechanisms used in this study. The safety data was consistent with the known safety profile established in first- and second-line MCRC 5. Prescribing Information Register for Updates References.

Summary of efficacy data from Avastin pivotal trials. Recommended dosing for approved cancer types. Overview gig proposed MOA of Avastin. Dosing and Usage Doses and Duration.

  AFTER THE NEOCONS AMERICA AT THE CROSSROADS PDF

Efficacy Data Recurrent Glioblastoma Studies. Do not administer Avastin for at least 28 days after surgery and until the wound is fully healed Discontinue in patients with wound healing complications requiring medical intervention Hemorrhage Severe or fatal hemorrhage have occurred Do not administer Avastin to patients with serious gg or recent history of hemoptysis Discontinue for Grade hemorrhage. Study design and patient population [ 1,54 ]. PFS data are based on investigator assessment.

Objective response rate ORR: Efficacy data overview [1]. Avastin plus chemotherapy carboplatin and paclitaxel demonstrated a 5.

Bevacizumab Approved by FDA to Treat Ovarian Cancer Following Surgery

OS results in patients with psOC who have not received more than 1 prior chemotherapy regimen [ 1 ] Median overall survival OS: Median progression-free survival PFS: Efficacy data overview [ 1 ]. The GOG study evaluated Avastin plus chemotherapy vs chemotherapy alone in platinum-sensitive ovarian cancer [ 1,3 ].

Upon completion of indicated cycles of combination therapy, Avastin is indicated for continued use as a single agent until disease progression in patients with platinum-sensitive recurrent ovarian cancer. The GOG study 0281 a diverse population of women [ 1 ]. Efficacy data goh in ITT 02188 [ 1 ]. The number of patients with measurable disease at baseline was in the Avastin plus chemotherapy arm and in the chemotherapy alone arm Median OS: Cohort analysis was exploratory.

Analysis not designed to evaluate statistical significance between treatment arms or compare among the 3 chemotherapy cohorts. Median OS by chemotherapy cohort.

Bevacizumab Approved by FDA to Treat Ovarian Cancer Following Surgery

ORR by chemotherapy cohort. Your email has been sent! Thanks for sharing this page.